Frank C. Grenier
15Patents
4h-index
31Co-inventors
60Inventor score
Filing activity: Apr 7, 1987 → Dec 13, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5635406A | Stabilized standards and calibrators containing rapamycin and tacrolimus bound to anti-rapamycin and anti-tacrolimus antibodies | Emerging Cross-Sectional Technologies | 21 | Expired |
| US6166660A | Driveway alarm system | Performing Operations; Transporting | 20 | Expired |
| US5338684A | Stable aqueous FK506 standards | Emerging Cross-Sectional Technologies | 16 | Expired |
| US4788136A | Diagnostic immunoassay by solid phase separation for digoxin | Emerging Cross-Sectional Technologies | 12 | Expired |
| US8846036B2 | Antibodies that bind to mammalian NGAL and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US5736401A | Stabilized standards and calibrators containing rapamycin and tactrolimus bound to FK binding proteins | Emerging Cross-Sectional Technologies | 3 | Expired |
| US7914999B2 | Non-denaturing lysis reagent | Physics | 2 | Active |
| US7883855B2 | Immunosuppressant drug extraction reagent for immunoassays | Emerging Cross-Sectional Technologies | 2 | Active |
| US8394606B2 | Neutrophil gelatinase-associated lipocalin (NGAL) protein isoforms enriched from urine and recombinant chinese hamster ovary (CHO) cells and related compositions, antibodies, and methods of enrichment, analysis and use | Physics | 2 | Active |
| US8221986B2 | Diagnostic test for the detection of a molecule or drug in whole blood | Physics | 2 | Active |
| US8697365B2 | Non-denaturing lysis reagent | Physics | 1 | Active |
| US5003054A | Ouabain triacetate derivative compounds | Chemistry; Metallurgy | 1 | Expired |
| US9636398B2 | Composition and method for the diagnosis and treatment of iron-related disorders | Physics | 1 | Active |
| US8440416B2 | Diagnostic test for the detection of a molecule or drug in whole blood | Physics | 0 | Active |
| US8541554B2 | Immunosuppressant drug extraction reagent for immunoassays | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.